Clinical Trial Update: Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating quantitative methods to guide rational treatment for anxiety in Parkinson disease; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Parkinson Disease

Snippet

Sponsor: Johns Hopkins University | Conditions: Anxiety Disorders, Parkinson Disease | Phase 4 | Status: TERMINATED | Results posted: 2020-03-19